Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Ross

Showing results (11-20 of 495) with videos related to

Pageof 50
Sort By:
Drug News & Perspectives|March 31, 2009
Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapyJeffrey S Ross
Drug News & Perspectives|February 16, 2010
Biomarker update for breast, colorectal and non-small cell lung cancerJeffrey S Ross
Expert Review of Molecular Diagnostics|November 1, 2005
Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?Jeffrey S Ross
AJNR. American Journal of Neuroradiology|June 8, 2023
PerspectivesJeffrey S Ross
Biomarkers in Medicine|June 11, 2011
Update on HER2 testing for breast and upper gastrointestinal tract cancersJeffrey S Ross
Advances in Anatomic Pathology|August 25, 2007
The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic testJeffrey S Ross
Archives of Pathology & Laboratory Medicine|January 26, 2012
Clinical implementation of KRAS testing in metastatic colorectal carcinoma: the pathologist's perspectiveJeffrey S Ross
Drug News & Perspectives|April 3, 2009
The newest stage in the evolution of drug developmentJeffrey S Ross
American Journal of Clinical Pathology|July 28, 2010
Saving lives with accurate HER2 testingJeffrey S Ross
The Oncologist|June 30, 2010
Measuring circulating miRNAs: the new "PSA" for Breast Cancer?Jeffrey S Ross
Pageof 50

Showing results (11-20 of 495) with videos related to

Sort By:
Pageof 50
Drug News & Perspectives|March 31, 2009
Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapyJeffrey S Ross
Drug News & Perspectives|February 16, 2010
Biomarker update for breast, colorectal and non-small cell lung cancerJeffrey S Ross
Expert Review of Molecular Diagnostics|November 1, 2005
Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?Jeffrey S Ross
AJNR. American Journal of Neuroradiology|June 8, 2023
PerspectivesJeffrey S Ross
Biomarkers in Medicine|June 11, 2011
Update on HER2 testing for breast and upper gastrointestinal tract cancersJeffrey S Ross
Advances in Anatomic Pathology|August 25, 2007
The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic testJeffrey S Ross
Archives of Pathology & Laboratory Medicine|January 26, 2012
Clinical implementation of KRAS testing in metastatic colorectal carcinoma: the pathologist's perspectiveJeffrey S Ross
Drug News & Perspectives|April 3, 2009
The newest stage in the evolution of drug developmentJeffrey S Ross
American Journal of Clinical Pathology|July 28, 2010
Saving lives with accurate HER2 testingJeffrey S Ross
The Oncologist|June 30, 2010
Measuring circulating miRNAs: the new "PSA" for Breast Cancer?Jeffrey S Ross
Pageof 50